Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;28(2):799-805.
doi: 10.1007/s40199-020-00358-5. Epub 2020 Jul 3.

Short and long term impacts of COVID-19 on the pharmaceutical sector

Nayyereh Ayati  1 , Parisa Saiyarsarai  1   2 , Shekoufeh Nikfar  3   4   5
Affiliations

Short and long term impacts of COVID-19 on the pharmaceutical sector

Nayyereh Ayati et al. Daru. 2020 Dec.

Abstract

Background: The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio-economic burden.

Objectives: Current short communication study assessed pharmaceutical market crisis during the COVID-19 era; discussing short- and long-term impacts of the pandemic on the pharmaceutical sector.

Results: Short-term impacts of COVID-19 pandemic includes demand changes, regulation revisions, research and development process changes and the shift towards tele-communication and tele-medicine. In addition, industry growth slow-down, approval delays, moving towards self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical dilemma could be anticipated as long-term impacts of COVID-19 pandemic on pharmaceutical sector in both global and local levels.

Conclusion: The pandemic of COVID-19 poses considerable crisis on the health markets, including the pharmaceutical sector; and identification of these effects, may guide policy-makers towards more evidence-informed planning to overcome accompanying challenges. Graphical abstract .

Keywords: COVID-19; Corona virus; Health market; Pharmaceutical industry; Pharmaceutical market; SARS-CoV-2; Tele-health.

PubMed Disclaimer

Conflict of interest statement

All the authors declare no conflict of interests which may affect our objectivity.

Figures

Graphical abstract
Graphical abstract
.
See this image and copyright information in PMC

References

    1. Title of subordinate document. In: Coronavirus disease (COVID-19) outbreak situation. WHO. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 23 April 2020.
    1. How to Design and Implement a National Drug Policy. Geneva: World Health Organization; 2001.
    1. Kebriaeezadeh A, Koopaei NN, Abdollahiasl A, Nikfar S, Mohamadi N. Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries. DARU J Pharm Sci. 2013;21(1):52. doi: 10.1186/2008-2231-21-52. - DOI - PMC - PubMed
    1. Cheraghali AM. Trends in Iran pharmaceutical market. Iran J Pharm Res: IJPR. 2017;16(1):1–7. doi: 10.18579/jpcrkc/2017/16/1/112466. - DOI - PMC - PubMed
    1. Cheraghali AM, Nikfar S, Behmanesh Y, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. Eastern Mediterr Health J = La Revue de Sante de la Mediterranee Orientale = Al-majallah Al-sihhiyah Li-sharq Al-mutawassit. 2004;10(3):406–415. - PubMed

Substances